 |
N2′-Deacetyl-N2′-[4-methyl-4-(oxobutyldithio)-1-oxopentyl]-maytansine-chimerised anti-CD138 IgG4 Monoclonal Antibody |
|---|---|
| Trade Name | |
| Orphan Indication | Multiple myeloma |
| EU Market Approval | EU |
| EU Designation Date | 2008-12-03 00:00:00 |
| Sponsor | Biotest AG |
Related Access Program
AbbVie – Multiple Myeloma
Janssen Research & Development, LLC – Multiple Myeloma
Dana-Farber Cancer Institute – Multiple Myeloma
Bristol-Myers Squibb – Multiple Myeloma
Peking University – Multiple Myeloma
Novartis Pharmaceuticals – Multiple Myeloma
Onyx Pharmaceuticals, Inc., an Amgen subsidiary – Multiple myeloma